Quote | Passage Bio Inc. (NASDAQ:PASG)
Last: | $1.31 |
---|---|
Change Percent: | 0.0% |
Open: | $1.34 |
Close: | $1.31 |
High: | $1.38 |
Low: | $1.3 |
Volume: | 41,004 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Passage Bio Inc. (NASDAQ:PASG)
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, and Eden Fucci,...
2024-03-06 13:52:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Passage Bio (NASDAQ: PASG ) just reported results for the fourth quarter of 2023. Passage Bio reported earnings per share of -30 cents. This was above the analyst estimate...
Message Board Posts | Passage Bio Inc. (NASDAQ:PASG)
Subject | By | Source | When |
---|---|---|---|
So...anybody out there? Thoughts on upcoming abstract, etc? | catinhat | investorshub | 05/10/2022 7:16:39 PM |
PASG down from panic selling due to the | dealerschool2006 | investorshub | 01/22/2021 6:37:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Passage Bio Inc. Company Name:
PASG Stock Symbol:
NASDAQ Market:
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, and Eden Fucci,...
$10,000 scholarship to be awarded to a rising junior with a life science major attending a Pennsylvania-based four-year college or university Scholarship application deadline is April 26 for the initial award in the fall of 2024 PHILADELPHIA, March 05, 2024 (GLOBE NEWSWIRE) -- Pas...